(MTZ) MasTec - Overview
Sector: IndustrialsIndustry: Engineering & Construction | Exchange NYSE (USA) | Currency USD | Market Cap: 25.528m | Total Return 166% in 12m
Stock: Energy Infrastructure, Communications, Pipelines, Civil Construction, Power
| Risk 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Relative Tail Risk | -1.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.51 |
| Alpha | 139.12 |
| Character TTM | |
|---|---|
| Beta | 1.653 |
| Beta Downside | 0.944 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.01% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Description: MTZ MasTec March 05, 2026
MasTec Inc. (MTZ) is an infrastructure construction company operating primarily in the United States and Canada. The company provides engineering, installation, maintenance, and upgrade services across various sectors. Infrastructure construction is a capital-intensive industry with long project cycles.
MTZs business model is diversified across five segments: Communications, Clean Energy and Infrastructure, Power Delivery, Pipeline Infrastructure, and Other. This diversification helps mitigate risks associated with reliance on a single industry. The companys services include building wireless and fiber optic networks, renewable energy facilities, and natural gas pipelines. The construction industry is cyclical, often influenced by economic growth and government spending.
MasTec serves a broad customer base, including telecommunication companies, energy providers, pipeline operators, and government entities. The company also offers maintenance and upgrade services, providing recurring revenue streams. For further detailed analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Communications infrastructure spending drives revenue growth
- Clean energy project backlog impacts future earnings
- Pipeline infrastructure demand fluctuates with energy prices
- Power delivery modernization boosts utility contracts
- Interest rate hikes increase borrowing costs
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 399.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -8.79 > 1.0 |
| NWC/Revenue: 7.40% < 20% (prev 5.31%; Δ 2.09% < -1%) |
| CFO/TA 0.05 > 3% & CFO 545.7m > Net Income 399.0m |
| Net Debt (2.40b) to EBITDA (1.12b): 2.15 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.7m) vs 12m ago -0.42% < -2% |
| Gross Margin: 11.76% > 18% (prev 0.11%; Δ 1.17k% > 0.5%) |
| Asset Turnover: 149.7% > 50% (prev 137.1%; Δ 12.64% > 0%) |
| Interest Coverage Ratio: 3.98 > 6 (EBITDA TTM 1.12b / Interest Expense TTM 173.0m) |
Altman Z'' 2.45
| A: 0.10 (Total Current Assets 4.33b - Total Current Liabilities 3.27b) / Total Assets 10.13b |
| B: 0.27 (Retained Earnings 2.71b / Total Assets 10.13b) |
| C: 0.07 (EBIT TTM 688.4m / Avg Total Assets 9.55b) |
| D: 0.39 (Book Value of Equity 2.67b / Total Liabilities 6.79b) |
| Altman-Z'' Score: 2.45 = A |
Beneish M -2.98
| DSRI: 1.04 (Receivables 3.54b/2.94b, Revenue 14.30b/12.30b) |
| GMI: 0.93 (GM 11.76% / 10.98%) |
| AQI: 0.95 (AQ_t 0.36 / AQ_t-1 0.38) |
| SGI: 1.16 (Revenue 14.30b / 12.30b) |
| TATA: -0.01 (NI 399.0m - CFO 545.7m) / TA 10.13b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of MTZ shares?
Over the past week, the price has changed by +5.13%, over one month by +6.04%, over three months by +41.86% and over the past year by +166.02%.
Is MTZ a buy, sell or hold?
- StrongBuy: 11
- Buy: 3
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MTZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 337.5 | 6.8% |
| Analysts Target Price | 337.5 | 6.8% |
MTZ Fundamental Data Overview March 27, 2026
P/E Forward = 34.3643
P/S = 1.7853
P/B = 7.2758
P/EG = 1.8272
Revenue TTM = 14.30b USD
EBIT TTM = 688.4m USD
EBITDA TTM = 1.12b USD
Long Term Debt = 2.18b USD (from longTermDebt, last quarter)
Short Term Debt = 330.0m USD (from shortTermDebt, last quarter)
Debt = 2.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.40b USD (from netDebt column, last quarter)
Enterprise Value = 27.93b USD (25.53b + Debt 2.80b - CCE 396.0m)
Interest Coverage Ratio = 3.98 (Ebit TTM 688.4m / Interest Expense TTM 173.0m)
EV/FCF = 134.5x (Enterprise Value 27.93b / FCF TTM 207.6m)
FCF Yield = 0.74% (FCF TTM 207.6m / Enterprise Value 27.93b)
FCF Margin = 1.45% (FCF TTM 207.6m / Revenue TTM 14.30b)
Net Margin = 2.79% (Net Income TTM 399.0m / Revenue TTM 14.30b)
Gross Margin = 11.76% ((Revenue TTM 14.30b - Cost of Revenue TTM 12.62b) / Revenue TTM)
Gross Margin QoQ = 10.08% (prev 13.56%)
Tobins Q-Ratio = 2.76 (Enterprise Value 27.93b / Total Assets 10.13b)
Interest Expense / Debt = 1.60% (Interest Expense 44.6m / Debt 2.80b)
Taxrate = 12.06% (21.0m / 174.0m)
NOPAT = 605.4m (EBIT 688.4m * (1 - 12.06%))
Current Ratio = 1.32 (Total Current Assets 4.33b / Total Current Liabilities 3.27b)
Debt / Equity = 0.86 (Debt 2.80b / totalStockholderEquity, last quarter 3.26b)
Debt / EBITDA = 2.15 (Net Debt 2.40b / EBITDA 1.12b)
Debt / FCF = 11.58 (Net Debt 2.40b / FCF TTM 207.6m)
Total Stockholder Equity = 3.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.18% (Net Income 399.0m / Total Assets 10.13b)
RoE = 13.08% (Net Income TTM 399.0m / Total Stockholder Equity 3.05b)
RoCE = 13.17% (EBIT 688.4m / Capital Employed (Equity 3.05b + L.T.Debt 2.18b))
RoIC = 11.33% (NOPAT 605.4m / Invested Capital 5.35b)
WACC = 10.77% (E(25.53b)/V(28.33b) * Re(11.80%) + D(2.80b)/V(28.33b) * Rd(1.60%) * (1-Tc(0.12)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Terminal Value 68.07% ; FCFF base≈513.7m ; Y1≈490.9m ; Y5≈475.5m
[DCF] Fair Price = 39.89 (EV 5.55b - Net Debt 2.40b = Equity 3.15b / Shares 78.9m; r=10.77% [WACC]; 5y FCF grow -5.86% → 3.0% )
EPS Correlation: 54.38 | EPS CAGR: 49.06% | SUE: 0.89 | # QB: 1
Revenue Correlation: 84.46 | Revenue CAGR: 20.56% | SUE: 2.22 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.16 | Chg7d=+0.000 | Chg30d=+0.131 | Revisions Net=+4 | Analysts=14
EPS current Year (2026-12-31): EPS=8.51 | Chg7d=+0.012 | Chg30d=+0.355 | Revisions Net=+9 | Growth EPS=+29.9% | Growth Revenue=+19.1%
EPS next Year (2027-12-31): EPS=10.66 | Chg7d=+0.042 | Chg30d=+0.604 | Revisions Net=+10 | Growth EPS=+25.3% | Growth Revenue=+9.3%
[Analyst] Revisions Ratio: +0.50 (6 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 10.2% (Discount Rate 11.8% - Earnings Yield 1.6%)
[Growth] Growth Spread = +8.4% (Analyst 18.6% - Implied 10.2%)